Key result
Cumulative hs-CRP burden linked to ~24% higher MACE risk without elevated LDL-c.
Cohort (n=36,421)
Answers are grounded in this paper and cite their sources.
BACKGROUND: This study aims to demonstrate the impact of the cumulative burden of low density lipoprotein-cholesterol (cumLDL-c) and high sensitivity C-reactive protein (cumhs-CRP) on cardiovascular risk. RESULTS: During the 4.62 (±0.70) years of follow-up, 2,148 (5.92%) participants had MACE. Both of cumLDL-c and cumhs-CRP were independent risk factors for MACE. In participants without cumLDL-c during 2006-2013, the participants with cumhs-CRP had higher MACE risk during the subsequent 5 years, than those without cumhs-CRP (hazard ratio [HR]: 1.24, 95% confidence interval [CI]:1.04-1.47). In addition, cumhs-CRP correlated with MACE in a cumhs-CRP level-dependent pattern. CONCLUSION: This study validated the effects of residual inflammation risk in patients with low LDL-c Level in a general population, using long-term burdens of hs-CRP or LDL-c other than a single time-point level. METHOD: The Kailuan study is a prospective, population-based study began in 2006. These total 36,421 participants completed 4 measurements of hs-CRP and LDL-c biennially from 2006-2013. Cumhs-CRP or cumLDL-c levels were calculated as the number of interval years multiplied by the Δhs-CRP (more than 2.0 mg/L) or ΔLDL-c (more than 2.6 mmol/L). Outcomes measured during follow-up (2012-2017) were defined as major adverse cardiac events (MACE), including ischemic stroke, myocardial infarction, and all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Mo et al. (2020) conducted a cohort in Cardiovascular risk (n=36,421). Cumulative burden of high sensitivity C-reactive protein (cumhs-CRP) vs. No cumulative burden of hs-CRP was evaluated on Major adverse cardiac events (MACE), including ischemic stroke, myocardial infarction, and all-cause mortality (HR 1.24, 95% CI 1.04-1.47). A cumulative burden of hs-CRP increased the risk of major adverse cardiac events in participants without a cumulative burden of LDL-c (HR 1.24; 95% CI 1.04-1.47).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: